|
KLF9 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.702400E-03 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
8.435200E-01 |
| Normal-vs-Stage2 |
2.237600E-02 |
| Normal-vs-Stage3 |
3.58629999996918E-06 |
| Normal-vs-Stage4 |
9.73899960676761E-10 |
| Stage1-vs-Stage2 |
2.874200E-02 |
| Stage1-vs-Stage3 |
1.74970000044183E-07 |
| Stage1-vs-Stage4 |
9.6508356861591E-12 |
| Stage2-vs-Stage3 |
2.731200E-01 |
| Stage2-vs-Stage4 |
2.338100E-02 |
| Stage3-vs-Stage4 |
8.705800E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.201700E-03 |
| Normal-vs-AfricanAmerican |
4.110000E-01 |
| Normal-vs-Asian |
5.850200E-01 |
| Caucasian-vs-AfricanAmerican |
3.280000E-01 |
| Caucasian-vs-Asian |
9.002000E-01 |
| AfricanAmerican-vs-Asian |
7.950800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.430400E-04 |
| Normal-vs-Female |
1.720400E-01 |
| Male-vs-Female |
3.702200E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
7.053900E-02 |
| Normal-vs-Age(41-60Yrs) |
1.660030E-01 |
| Normal-vs-Age(61-80Yrs) |
4.033600E-04 |
| Normal-vs-Age(81-100Yrs) |
1.883940E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.370400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.567600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.906400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.012270E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.360200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.658400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
4.695900E-02 |
| Normal-vs-Grade 2 |
9.321600E-01 |
| Normal-vs-Grade 3 |
1.76860000000723E-06 |
| Normal-vs-Grade 4 |
5.1900039821362E-11 |
| Grade 1-vs-Grade 2 |
4.405800E-02 |
| Grade 1-vs-Grade 3 |
5.755400E-03 |
| Grade 1-vs-Grade 4 |
1.896100E-03 |
| Grade 2-vs-Grade 3 |
9.83799997023027E-09 |
| Grade 2-vs-Grade 4 |
1.32116539930394E-13 |
| Grade 3-vs-Grade 4 |
2.581000E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
3.157800E-01 |
| Normal-vs-ccB subtype |
5.57149999469431E-08 |
| ccA subtype-vs-ccB subtype |
1.66267000167863E-12 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.058450E-03 |
| Normal-vs-N1 |
4.31670000000661E-06 |
| N0-vs-N1 |
1.131850E-02 |
|
|
